流行病学,纤维素原,凝块特性和心血管疾病风险 - - 从非洲的角度来看
Marlien Pieters1,2, Zelda de Lange-Loots1,2
1Centre of Excellence for Nutrition, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
Research and practice in thrombosis and haemostasis
|December 29, 2025
概括
流行病学研究显示,生活方式和遗传因素影响了非洲裔人的血栓特性和心血管疾病风险. 了解这些人口特异性因素对于有效的预防策略至关重要.
科学领域:
- 心血管流行病学心血管流行病学
- 血栓形成和血液静止.
- 人口遗传学 人口遗传学
背景情况:
- 改变的纤维素凝块结构有助于血栓形成,但人口层面的数据很少.
- 大多数关于凝块特性和心血管疾病风险的证据来自小型研究或非人类模型.
- 流行病学研究可以确定影响凝块性能的生活方式,人口统计和遗传因素.
研究的目的:
- 从非洲的角度审查纤维素素,凝块性质和心血管疾病风险的流行病学证据.
- 探索人口层面对凝块特性的影响,包括基因与环境的相互作用.
- 突出了在2025年国际血栓与血液静止学会 (ISTH) 大会上提出的研究成果.
主要方法:
- 对流行病学证据的审查,主要来自非洲血统的个人.
- 影响纤维素度和凝块特性 (例如纤维结构,溶解抵抗) 的因素分析.
- 在非洲人口中检查遗传分析和基因环境相互作用.
主要成果:
- 肥胖,脂质不良,炎症,血糖控制不良和衰老在非洲人中促进了前血栓凝块的特性,类似于欧洲人.
- 较高的HDL胆固醇和适度的酒精摄入量显示出保护作用.
- 遗传分析揭示了非洲人的独特特征,使得能够检测出独特的基因环境相互作用,影响凝块特性,而不依赖于纤维素原水平.
结论:
- 纤维素生物是复杂的,功能性凝块特性对于疾病风险评估至关重要.
- 针对特定人群的研究,特别是在非洲,对于制定有针对性的预防策略至关重要.
- 基因与环境的相互作用显著改变了凝块的特性及其对不同种群中代谢因素的反应.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:16Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
01:24Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
01:30Venous Thrombosis I: Introduction
267
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
267
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
01:09Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K